Literature DB >> 10897530

The use of HRT in patients with breast cancer: yes, no, or sometimes?

J Stebbing, R K Gregory.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10897530      PMCID： PMC1313697     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  7 in total

1.  Mortality variations as a measure of general practitioner performance: implications of the Shipman case.

Authors:  S Frankel; J Sterne; G D Smith
Journal:  BMJ       Date:  2000-02-19

2.  All changed, changed utterly. British medicine will be transformed by the Bristol case.

Authors:  R Smith
Journal:  BMJ       Date:  1998-06-27

Review 3.  Tamoxifen in the treatment of breast cancer.

Authors:  C K Osborne
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

4.  Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women.

Authors:  P D Delmas; N H Bjarnason; B H Mitlak; A C Ravoux; A S Shah; W J Huster; M Draper; C Christiansen
Journal:  N Engl J Med       Date:  1997-12-04       Impact factor: 91.245

5.  The association of replacement estrogens with breast cancer.

Authors:  A M Nomura; L N Kolonel; T Hirohata; J Lee
Journal:  Int J Cancer       Date:  1986-01-15       Impact factor: 7.396

Review 6.  Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.

Authors:  R Fossati; C Confalonieri; V Torri; E Ghislandi; A Penna; V Pistotti; A Tinazzi; A Liberati
Journal:  J Clin Oncol       Date:  1998-10       Impact factor: 44.544

7.  Menopausal estrogen use and risk of breast cancer.

Authors:  L A Brinton; R N Hoover; M Szklo; J F Fraumeni
Journal:  Cancer       Date:  1981-05-15       Impact factor: 6.860
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.